ORIGINAL RESEARCH
Published on 11 Aug 2025
Multinational cost-effectiveness analysis of pembrolizumab combined with chemotherapy as first-line treatment for advanced biliary tract cancer
doi 10.3389/fpubh.2025.1597550
- 368 views
34
Total downloads
1,049
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.